HAT1 and melanoma: These studies identified the upregulation of the Ras, MAPK, Wnt, and TGF-β signaling pathways in melanoma cells lacking HAT1. We then confirmed that among these four upregulated signaling pathways, the MAPK pathway was significantly upregulated in BRAFi-resistant cells, following the loss of HAT1 expression.